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INTRODUCTION
With the development of implantology, installation 
of dental implants and rehabilitation in severely atro-
phic bone area became more routine procedures at 
dental clinics. However,the need for enough bone 
support and sufficient bone architecture still exists in 
most of clinical cases. Among the available materials 
used for bone reconstruction, autogenous bone is cur-
rently the gold-standard because it is a source of 
osseous matrix, cells, and growth modulating mole-
cules
1)
. However, the use of autogenous bone is lim-
ited by donor site morbidity, the quantity of donor 
bone, frequent infections and unpredictable resorption 
that may compromise aesthetics and function. To 
overcome the limits of autogenous bone, various sub-
stitutive biomaterials are proposed. Materials of hu-
man and animal origin have the potential risk of cross 
contamination and the disadvantages of limited sup-
ply
2,3)
. As a consequence, synthetic products as the 
biphasic calcium phosphate (BCP) which is a mixture 
of hydroxyapatite (HA) and β-tricalcium phosphate 
(β-TCP) were introduced
4-7)
. 
Previous reports have shown that HA particles did 
not elicit an inflammatory response and they provided 
a good scaffold for the new bone to grow in. However, 
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Purpose: Synthetic bone products such as biphasic calcium phosphate (BCP) are mixtures of hydroxyapatite (HA) and β-
tricalcium phosphate (β- TCP). In periodontal therapies and implant treatments, BCP provides to be a good bone 
reconstructive material since it has a similar chemical composition to biological bone apatites. The purpose of this study was 
to compare bone regeneration capacity of two commercially available BCP. 
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β- TCP (70:30) and BCP with Silicon-substituted hydroxyapatite (Si-HA) and β-TCP (60:40) particles were filled in each 
defect. Control defects were filled with only blood clots. Animals were sacrificed at 4 and 8 week postoperatively. 
Histomorphometric analysis was performed.
Results: BCP with HAand β- TCP 8 weeks group and BCP with Si-HA and β- TCP 4 and 8 weeks groups showed 
statistically significant in crease (P <0.05) in augmented area than control group. Newly formed bone area after 4 and 8 
weeks was similar among all the groups. Residual materials were slightly more evident in BCP with HA and β- TCP 8 
weeks group.
Conclusions: Based on histological results, BCP with HA and β- TCP and BCP with Si-HA and β- TCP appears to 
demonstrate acceptable space maintaining capacity and elicit significant new bone formation when compared to natural bone 
healing in 4 and 8 week periods. (J Korean Acad Periodontol 2009;39:223-230)
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HA particles failed to show evidence of new perio-
dontal tissue attachment, osteogenesis, or cemento-
genesis in the treatment of periodontal osseous de-
fects
8-10)
. It was rather suspected that the material 
produced a response like a well-tolerated foreign body 
within the host connective tissue. On the contrary, β
-TCP was reported to resorb unpredictably in biologic 
fields and not to provide a predictable scaffold for 
new bone to grow in
11-13)
. However the combination of 
HA and β-TCP and the development of two-phased 
calcium phosphate or biphasic calcium phosphate ce-
ramic made it possible to control the resorbability of 
the material and at the same time maintain its osteo-
conductive property
14)
. 
In many cases of bone grafts in implant surgeries, 
BCP provides good bone reconstruction since it has 
similar chemical composition to biological bone 
apatites. Also it has been proved of its efficacy as a 
bone substitute material in many human clinical ap-
plications
3,15,16)
. There has been lots of trials to find 
ideal combination of HA/β-TCP ratio to maximize 
bone regeneration capacity. Early studies have shown 
that approximately 60% of HA and 40% of β-TCP 
seemed to provide a reasonable bone conductive prop-
erty
3,10,14,17)
. However the optimal ratio is still not 
determined. Consequently, many manufactures have 
come up with their unique combinations of HA/β-
TCP.
The Si-substituted macroporous biphasic calcium 
phosphate (Bonemedik-DM◯R, META bio med Co. Ltd., 
Chungwongun, Korea) is a mixture of HA and β-TCP 
with a ratio of 60 : 40. The material is manufactured 
by substituting silicon (Si) ions of HA into phosphate 
(P) sites and mixing β-TCP  granules with HA par-
ticles to enhance both physical and chemical factors
18)
. 
The presence of silicon in HA is knownto play an im-
portant part on the formation of bone
19)
. The overall 
granule sizes are from 0.25 to 1 mm. The other prod-
uct on the market (Osteon◯R, Genoss. Co. Ltd., Suwon, 
Korea) is a mixture of HA and β-TCP with a ratio of 
70 : 30. The granule sizes are from 0.5 to 2 mm. 
The purpose of this study was to evaluate bone re-
generation capacity of two commercially available bi-
phasic calcium phosphate in rabbit calvarial defect.
MATERIALS AND METHODS
1. Animals
Sixteen 9-20 months old New Zealand White male 
rabbits (Oryctolagus cuniculus) were used. The ani-
mals were housed in cages and fed with standard ani-
mal food. This study has been reviewed and approved 
by the Institutional Animals Care and Use Committee, 
Yonsei Medical Center, Seoul, Korea. 
2. Surgical procedures
All surgeries were performed under sterile 
conditions. All rabbits were anesthetized with an in-
tramuscular (IM) injection of a solution of 91% ket-
amine hydrochloride (Ketalar◯R, Yuhan Co., Seoul, 
Korea) and 9% xylazine(Rumpun◯R, Bayer Korea Ltd., 
Seoul, Korea). Surgical area of cranium was anes-
thetized with 2% lidocaine and the scalps were shaved 
and disinfected. The calvariae were exposed through a 
mid-line skin incision. The periosteum was retracted 
laterally and bilaterally, and 8-mm-diameter defects 
were made in the parietal bones by means of a stand-
ardized trephine cutting bur under physiological saline 
solution irrgation
20)
.
Three defects were made per one animal in triangu-
lar shape with an inter defect distance of 3 mm to 
exclude any influence to different groups. To create 
the same environments, sagittal suture was avoided 
when creating defects. The defects were filled with 
the respective materials, with one cavity destined to 
the control group containing blood clot. The defect 
allocation was randomly assigned in each rabbit (Fig. 
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1). The graft materials were wetted in sterilized saline 
and gently packed into the defects. Particle size was 
1.0~2.0 mm of Osteon◯R and Bonemedik-DM◯R.
A B
C
Figure 1. Schematicdrawing of designated material filled in 
defects. Dotted line represents sagittal suture of cranium; 
A: Control, B: Bonemedik-DM
◯R
, C: Osteon
◯R
.
The periosteum was drawn over the defects and su-
tured by resorbable suture material (5-0 Vicryl◯R, 
Ethicon, Somerville, NJ, USA). Subcutaneous mucosa 
were adapted and sutured with resorbable suture ma-
terial (4-0 Vicryl◯R, Ethicon, Somerville, NJ, USA). 
Finally the skin was closed with 4-0 absorbable mon-
ofilament suture (Monosyn◯R, Braun, Tuttlingen, 
Germany). The sutures were removed after 10 days 
after the confirmation of intact closure of skin. The 
rabbits were sacrificed after 4 and 8 weeks. 
3. Histological preparation
The experimental specimens were obtained by using 
number 702 bur under physiological saline irrigation. 
The specimens were fixed in 10% formaldehyde sol-
ution for 10 days and they were processed to the rou-
tine procedures of slide preparation with 8 µm sec-
tions stained with Haematoxylin-Eosin (H-E) to be 
analyzed under an optical microscope (Olympus BX50, 
Olympus Optical Co., Tokyo, Japan).
4. Statistical analysis
Numerical data was presented as mean plus one 
standard deviation. One way analysis of variance 
(ANOVA) with Holm-Sidak method was used for mul-
tiple comparisons to compare with the control. The 
probability level of P < 0.05 was regarded as statisti-
cally significant.
RESULTS
1. Histological observation
All treatment and control sites healed uneventfully 
with no clinical evidence of inflammatory response to 
the graft material. Also the distribution of residual 
graft materials was homogeneous on the surface of the 
bone defect, regardless of group (Osteon, Bonemedik-DM). 
For the control group, the perforated areas were 
filled with loose fibrous tissue and a few newly 
formed bone was observed. A slight decrease in bone 
ingrowth towards the center of the defect could be 
observed compared to test groups (Fig. 2, 3).
For the Osteon group, lamellar bone was apposed in 
close contact at the surface of the granules and con-
sequent bone ingrowth was observed in both 4 and 8 
weeks. However, relatively large particles of Osteon◯R 
were evident in 4 weeks which were in the middle of 
resorption and substitution into new bone. On the 
contrary, particle size and total area were reduced in 
8 weeks. Also the density of newly formed bone was 
higher compared to 4 week. Fibrous tissues were still 
observed between the granules (Fig. 4, 5).
For the Bonemedik-DM group, particles were in-
corporated in mature new bone and were resorbed 
during the remodeling process in 4 weeks. The in-
dividual particles were clearly identifiable and they 
were surrounded by varying amounts of newly formed 
bone without being encapsulated by loose fibrous con-
nective tissues. The amount of bone ingrowth was 
greater than for the Osteon group. Small particles 
surrounded by new bone were present between the 
larger ones (Fig. 6, 7). 
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A                                                                                      B 
Figure 2. Light micrographs of control group at 4 weeks postoperatively. Thick fibrous tissue is covering the defect ×6 (A), ×200 (B).
A                                                                                      B 
Figure 3. Light micrographs of control group at 8 weeks postoperatively. Mature bone tissue is observed among connective
tissue ×16 (A), ×200 (B).
A                                                                                      B 
Figure 4. Light micrographs of Osteon group at 4 weeks postoperatively. Relatively large particle of residual materials are
surrounded obsteoblasts and newly formed bone ×16 (A), ×200 (B). 
A                                                                                      B 
Figure 5. Light micrographs of Osteon group at 8 weeks postoperatively. Relatively small particles are scattered and newly 
formed bone are surrounding  ×16 (A), ×200 (B).
1mm
1mm
1mm
1mm
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Relatively irregular inner surface of unresorbed ce-
ramic particles of Bonemedik-DM group indicates that 
resorption process took place before deposition of 
mineralized bone matrix. On the contrary, relatively 
smooth appearing inner surface was found in Osteon 
group. 
2. Histomorphometric analysis
Bone substitutes are recognized through bone 
growth from the host bone to the graft, and pro-
gressing from the outer part to the core by 
osteoconduction. There were osteoblastic and osteoid 
layers at the border of the defect and around grafted 
particles in Osteon and Bonemedik-DM groups. The 
total area of augmentation, bone area, residual mate-
rial area and soft tissue area were measured. 
Total augmented area including bone area, residual 
materials and soft tissue area was higher in Osteon 4 
and 8 week groups and Bonemedik-DM 4 and 8 week 
groups than the control group (Table 1, Fig. 2, 3). 
These results were statistically significant (P<0.05). 
Bone area at 4 week was slightly higher in Bonemedick- 
DM group which means early bone ingrowth. On the 
contrary, Osteon group showed more bone area than 
Bonemedik-DM group. Residual materials were de-
creased in both Osteon and Bonemedik- DM groups 
with no statistical significance. Soft tissue area was 
dominantly wider in Bonemedik-DM groups regardless 
of weeks. In grafted groups, total amount of bone 
formation and residual materials exceed or is equal to 
control groups. 
DISCUSSION
In the scope of bone regeneration, the augmentation 
of bone defects using autogenous bone to be the gold 
A                                                                                      B 
Figure 6. Light micrographs of Bonemedik-DM at 4 weeks postoperatively. Active resorption process is observed ×16 (A), ×200 (B).
A                                                                                      B 
Figure 7. Light micrographs of Bonemedik-DM at 8 weeks postoperatively. Mature bone tissue is apposed interspace of re-
sidual materials ×16 (A), ×200 (B).
1mm
1mm
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standard. However, autogenous bone is not always 
available in sufficient volume according to clinical 
situations. Therefore various methods such as graft 
materials and growth factors are proposed to replace 
autogenous bone. Currently various growth factors 
such as TGF-β, PDGF, and VEGF are studied to stim-
ulate regeneration of bone tissue in several ways
21-23)
. 
Also rhBMP-2, recombinant human osteogenic pro-
tein-1 (rhOP-1/rhBMP-7), and recombinant human 
growth/differentiation factor-5 (rhGDF-5) are being 
pursued as therapies for reconstruction and repair of 
induced and congenital skeletal defects
24,25)
. However 
these growth factors are not well documented and 
commercially unavailable. Therefore, most of clinicians 
are prone to choose various grafting materials to 
overcome bone defects in implantology or periodontal 
therapies in most cases.
Calcium phosphate ceramics have long been inves-
tigated as biologically compatible material to used in 
the treatment of periodontal osseous defects and im-
plant surgery. Especially two-phased calcium phos-
phate or biphasic calcium phosphate ceramic was de-
veloped to control the resorbability of the material 
and at the same time maintain its osteoconductive 
property. The in vivo and in vitro dissolution of cal-
cium phosphate ceramics was found to be dependent 
on the composition, crystallinity, and pH of the sol-
ution
26)
. Kwon et al
27)
 reported that biphasic HA/β
-TCP composite powders showed average solubility 
between HA and β-TCP and concluded that the dis-
solution rate of the calcium phosphate powders was 
strongly dependent on the β-TCP content. It is well 
known that early resorption of materials cannot 
maintain appropriatespace to regenerate bone tissue. 
On the other hand, the delayed resorption of materials 
inhibits new bone formation. Therefore, appropriate 
timing of dissolution of BCP and choosing right ratio of 
HA/β-TCP is crucial to maximize bone regeneration.
Gauthier et al
28)
 used 60 % of HA and 40% of β
-TCP in extraction sockets in canine models to report 
that well formed cortical bone over the materials was 
present and it  inhibited the resorption of alveolar 
bone after 3 months. Nery et al
14)
 used different ratio 
of HA/β-TCP in canine models to prove that higher 
HA ratio showed accelerated new bone formation and 
new attachment levels. 
The results of this study indicated that the bone 
filling of calvarial defect realized with micro macro-
porous biphasic calcium phosphate granules after 4 to 
8 weeks have moderate bone ingrowth capacity and it 
appears to demonstrate a pattern that is higher HA 
ratio to β-TCP tends to show greater bone re-
generation as shown histologically. However, statisti-
cally significant different was not noted between 
Osteon and Bonemedik-DM. 
Total residual materials were much more abundant 
in Osteon 8 weeks group. This may be due to the low 
dissolution rate of porous HA
17)
 and easy resorbability 
Table 1. Histomophometric Results at 4 and 8 Weeks. All Parameters Are Expressed As mm
2
 (Group Mean±SD)
Bone area Residual material Soft tissue area Augmented area
Control 4 weeks 3.08 ± 0.92 N-A 2.07 ± 1.08 5.15 ± 1.07
Control 8 weeks 4.02 ± 0.41 N-A 3.79 ± 1.55 7.80 ± 1.90
*
BCP with HA and β -TCP (70:30) 
†
 4 weeks 2.43 ± 0.31 3.51 ± 0.98 2.29 ± 1.95 8.22 ± 2.35
BCP with HA and β -TCP (70:30) 8 weeks 3.09 ± 1.34 2.86 ± 0.92 3.04 ± 2.20 8.91 ± 1.34
*
BCP with Si-HA and β -TCP (60:40) 
‡
 4 weeks 2.83 ± 0.42 2.36 ± 0.58 3.36 ± 0.67 8.55 ± 0.45
*
BCP with Si-HA and β -TCP (60:40) 8 weeks 3.00 ± 0.93 1.96 ± 0.83 3.90 ± 1.93 8.86 ± 1.75
*
*
 : Significant statistical difference compared to corresponding control group at 4 weeks (P<0.05)
†
: Osteon
®
, Genoss. Co. Ltd., Suwon, Korea
‡
: Bonemedik-DM
®
, META bio med Co. Ltd., Chungwongun, Korea
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of β-TCP which were proven in vitro
29)
 and in 
vivo
12,30)
. Therefore the bone quality might be influ-
enced inferiorly by remaining particles. However, 
these residual materials may stay long enough for cell 
differentiation, maturation, and revascularization
31)
. 
Longer period of observation would be required to 
fully evaluate these results. 
The results from this study confirm the resorb-
ability on time of Osteon◯R and Bonemedik-DM◯R andthe 
scaffold effect of the HA content and high osteo-
conduction property. These two crucial properties in-
volved a balance of resorption and bone ingrowth at 
the expense of the micro-macropours bioceramics.
Although this study showed that the amount of 
bone regeneration of control sites was higher than 
graft sites, the BCP grafts also showed reasonable 
bone ingrowth and can be a good candidate to replace 
natural bone regeneration and to maintain space for 
longer period of time. Despite the limitation of this 
study because of small sample size, we could conclude 
that the higher portion of HA particles produced lon-
ger resorption period and maintained better bone 
structure. Also, graft of Osteon◯R and Bonemedik-DM◯R 
in the rabbit calvarial defects model was shown to be 
potentially beneficial at early bone healing.
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